Security
RAPHAEL PHARMACEUTICAL INC Common Stock · RAPH
RAPHOTCCommon stockCurrentCIK 1415397Updated Oct 6, 2026
Name history
Easy Energy Inc · through May 14, 2021
RAPH price & chart
Loading TradingView…
OTC:RAPH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
10-K filing
Show 5 more recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Other Events
Items 8.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 7,000Source | 51,000Source | 7,000Source | 30,000Source | 128,000Source | 3,000Source | 93,000Source | 353,000Source | 53,000Source | 27,000Source | 339,000Source | 333,000Source |
| Property, Plant and Equipment, NetUSD | 2,000Source | 2,000Source | 1,000Source | 2,000Source | — | 2,000Source | 2,000Source | — | 2,000Source | 2,000Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 40,000Source | — | 20,000Source | 120,000Source | — | 50,000Source | 287,000Source | — | 19,000Source | 230,000Source | 288,000Source |
| Assets, CurrentUSD | 5,000Source | 49,000Source | 6,000Source | 28,000Source | 126,000Source | 1,000Source | 91,000Source | 350,000Source | 51,000Source | 25,000Source | 337,000Source | 331,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 196,000Source | 187,000Source | 202,000Source | 196,000Source | 187,000Source | 202,000Source | 196,000Source | 187,000Source | 202,000Source | 187,000Source | 185,000Source | 157,000Source |
| Additional Paid in CapitalUSD | — | — | — | — | — | — | — | — | — | — | — | 5,975,000Source |
| Retained Earnings (Accumulated Deficit)USD | -9,895,000Source | -8,434,000Source | -10,620,000Source | -9,640,000Source | -8,108,000Source | -10,397,000Source | -9,318,000Source | -7,860,000Source | -10,168,000Source | -8,889,000Source | -7,310,000Source | -6,026,000Source |
| Stockholders' Equity Attributable to ParentUSD | -1,264,000Source | -616,000Source | -1,885,000Source | -1,048,000Source | -290,000Source | -1,662,000Source | -734,000Source | -103,000Source | -1,433,000Source | -742,000Source | -267,000Source | 106,000Source |
| Additional Paid in Capital, Common StockUSD | 8,435,000Source | 7,631,000Source | 8,533,000Source | 8,396,000Source | 7,631,000Source | 8,533,000Source | 8,388,000Source | 7,570,000Source | 8,533,000Source | 7,960,000Source | 7,392,000Source | — |
| Liabilities and EquityUSD | 7,000Source | 51,000Source | 7,000Source | 30,000Source | 128,000Source | 3,000Source | 93,000Source | 353,000Source | 53,000Source | 27,000Source | 339,000Source | 333,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,271,000Source | 667,000Source | 1,892,000Source | 1,078,000Source | 418,000Source | 1,665,000Source | 827,000Source | 456,000Source | 1,486,000Source | 769,000Source | 72,000Source | 227,000Source |
| Accounts Payable, CurrentUSD | — | — | — | — | — | — | — | — | 163,000Source | 125,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 343,000Source | 375,000Source | — | 152,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -3,358,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 197,000Source | 245,000Source | 350,000Source | 200,000Source | 2,290,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | — | — | — | — | -190,000Source | 102,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -44,000Source | -209,000Source | -210,000Source | -532,000Source | -1,203,000Source | -759,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | — | -2,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 240,000Source | 236,000Source | 321,000Source | 1,145,000Source | 896,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | — | — | — | — | -58,000Source | 135,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 3,000Source | 40,000Source | 1,000Source | 20,000Source | 1,000Source | 50,000Source | 45,000Source | 19,000Source | 230,000Source | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 178,000Source | 157,000Source | 159,000Source | 174,000Source | 186,000Source | 353,000Source | 614,000Source | 733,000Source | 703,000Source | 2,139,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -255,000Source | -326,000Source | -223,000Source | -322,000Source | -229,000Source | -429,000Source | -1,279,000Source | -1,519,000Source | -1,284,000Source | -3,358,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -1,284,000Source | -3,358,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,000Source | -7,000Source | -24,000Source | -7,000Source | -6,000Source | -4,000Source | -34,000Source | -10,000Source | -12,000Source | -41,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 240,000Source | 243,000Source | 280,000Source | — | — |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -251,000Source | -319,000Source | -199,000Source | -315,000Source | -223,000Source | -425,000Source | -1,245,000Source | -1,509,000Source | -1,272,000Source | -3,317,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -255,000Source | -326,000Source | -223,000Source | -322,000Source | -229,000Source | -429,000Source | -1,279,000Source | -1,519,000Source | -1,284,000Source | -3,358,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.01Source | 0.01Source | 0.01Source | 0.02Source | 0.01Source | 0.02Source | 0.07Source | 0.08Source | 0.07Source | 0.23Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.01Source | 0.01Source | 0.01Source | 0.02Source | 0.01Source | 0.02Source | 0.07Source | 0.08Source | 0.07Source | 0.23Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 19,626,418Source | 18,701,418Source | 20,176,418Source | 19,626,418Source | 20,176,418Source | 19,626,418Source | 19,551,719Source | 18,674,136Source | 16,716,905Source | 14,341,518Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 19,626,418Source | 18,701,418Source | 20,176,418Source | 19,626,418Source | 20,176,418Source | 19,626,418Source | 19,551,719Source | 18,674,136Source | 16,716,905Source | 14,341,518Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 178,000Source | 157,000Source | 159,000Source | 174,000Source | 186,000Source | 353,000Source | 614,000Source | 733,000Source | 703,000Source | 2,139,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -1,284,000Source | -3,358,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,000Source | -7,000Source | -24,000Source | -7,000Source | -6,000Source | -4,000Source | -34,000Source | -10,000Source | -12,000Source | -41,000Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 3,000Source | 3,000Source | — | — |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 38,000Source |
| Research and Development ExpenseUSD | — | — | 73,000Source | 162,000Source | 40,000Source | 141,000Source | 37,000Source | 72,000Source | 631,000Source | 776,000Source | 569,000Source | 1,178,000Source |